Jonathan Landa

A pilot trial evaluating lenalidomide and oral azacitidine with radiotherapy for patients with newly diagnosed and relapsed plasmacytoma

Urvi A. Shah, Andriy Derkach, Meghana Pagadala, Kelly Barnett et autres

us (code pays fourni par la source)

Concurrent administration of BCMA and GPRC5D chimeric antigen receptor (CAR) T cells in advanced multiple myeloma

Sham Mailankody, Sneha Mitra, Kevin Herrera, Bachisio Ziccheddu et autres

us (code pays fourni par la source)

Concurrent Administration of BCMA and GPRC5D Chimeric Antigen Receptor (CAR) T Cells for the Treatment of Relapsed or Refractory Multiple Myeloma: Results from the Phase I TANDEMM Clinical Trial

Sham Mailankody, Sneha Mitra, Kevin Herrera, Bachisio Ziccheddu et autres

Overall survival from the open label phase 2 trial of palbociclib in patients with advanced well differentiated/dedifferentiated liposarcoma.

Gary K. Schwartz, Mary Louise Keohan, Sandra P. D’Angelo, Mrinal M. Gounder et autres

us (code pays fourni par la source)

Phase I Trial of MCARH109, a G Protein–Coupled Receptor Class C Group 5 Member D (GPRC5D)–Targeted Chimeric Antigen Receptor T-Cell Therapy for Multiple Myeloma: An Updated Analysis

Eric M. Jurgens, Ross Firestone, Jagrutiben Chaudhari, Kinga Hosszu et autres

us (code pays fourni par la source)

P-038 Phase I Trial of MCARH109, a First-in-Class G Protein Coupled Receptor Class C Group 5 Member D (GPRC5D)-Targeted CAR T-cell Therapy for Relapsed or Refractory Multiple Myeloma: Updated Analysis

Eric Jurgens, Ross Firestone, Jagrutiben Chaudhari, Kinga Hosszu et autres

Supplementary Figure S12 from Therapy-Induced Senescence Contributes to the Efficacy of Abemaciclib in Patients with Dedifferentiated Liposarcoma

Caroline E. Gleason, Mark A. Dickson, Mary E. Klein, Cristina R. Antonescu et autres

Supplementary Figure S16 from Therapy-Induced Senescence Contributes to the Efficacy of Abemaciclib in Patients with Dedifferentiated Liposarcoma

Caroline E. Gleason, Mark A. Dickson, Mary E. Klein, Cristina R. Antonescu et autres

Supplementary Table S2 from Therapy-Induced Senescence Contributes to the Efficacy of Abemaciclib in Patients with Dedifferentiated Liposarcoma

Caroline E. Gleason, Mark A. Dickson, Mary E. Klein, Cristina R. Antonescu et autres

Supplementary Figure S3 from Therapy-Induced Senescence Contributes to the Efficacy of Abemaciclib in Patients with Dedifferentiated Liposarcoma

Caroline E. Gleason, Mark A. Dickson, Mary E. Klein, Cristina R. Antonescu et autres

Supplementary Figure S15 from Therapy-Induced Senescence Contributes to the Efficacy of Abemaciclib in Patients with Dedifferentiated Liposarcoma

Caroline E. Gleason, Mark A. Dickson, Mary E. Klein, Cristina R. Antonescu et autres

Supplementary Table S1 from Therapy-Induced Senescence Contributes to the Efficacy of Abemaciclib in Patients with Dedifferentiated Liposarcoma

Caroline E. Gleason, Mark A. Dickson, Mary E. Klein, Cristina R. Antonescu et autres